The definition of clinically significant prostate cancer is a dynamic process that was initiated
many decades ago, when there was already evidence that a great proportion of patients with …

Context An association between tobacco smoking and prostate cancer (PCa) incidence and
mortality was suggested in an earlier meta-analysis of 24 prospective studies in which dose …

Background Prostate tumor heterogeneity and biopsy undersampling pose challenges to
accurate, individualized risk assessment for men with localized disease. Objective To …

Multiparametric magnetic resonance imaging (mp-MRI) has shown excellent results in the
detection of prostate cancer (PCa). However, characterizing prostate lesions …

Objectives To evaluate the recommendations for multiparametric prostate MRI (mp-MRI)
interpretation introduced in the recently updated Prostate Imaging Reporting and Data …

Objective To assess the value of the Prostate Imaging Reporting and Data System (PI‐
RADS) scoring system, for prostate multi‐parametric magnetic resonance imaging (mp MRI) …

Multi-parametric MRI (mp-MRI) is considered the best non-invasive imaging modality for
diagnosing prostate cancer (PCa). However, mp-MRI for PCa diagnosis is currently limited …

Imaging has traditionally played a minor role in the diagnosis and staging of prostate cancer.
However, recent controversies generated by the use of prostate‐specific antigen (PSA) …

Purpose: A barrier to the acceptance of active surveillance for men with prostate cancer is
the risk of underestimating the cancer burden on initial biopsy. We assessed the value of …

Background Knowledge of significant prostate (sPCa) locations being missed with magnetic
resonance (MR)-and transrectal ultrasound (TRUS)-guided biopsy (Bx) may help to improve …